Global EditionASIA 中文雙語Fran?ais
    China
    Home / China / Health

    Country working on vaccines for novel coronavirus variants

    By ZOU SHUO and ZHANG YANGFEI | CHINA DAILY | Updated: 2021-03-29 07:18
    Share
    Share - WeChat
    Teachers and students are vaccinated at East China Normal University's Minhang campus stadium in Shanghai on Sunday. [Photo/XINHUA]

    Inoculations in use found to have a good neutralizing effect on strains

    China is advancing the development of COVID-19 vaccines against variants of the novel coronavirus, and experiments have shown the inactivated vaccines currently used in the country are effective against them.

    Zhang Yuntao, vice-president of China National Biotech Group, a subsidiary of State-owned pharmaceutical giant Sinopharm, told a news conference on Sunday that researchers have been testing the antiviral-mutation ability of the inactivated vaccines.

    By using data from mid-and late-stage clinical trials in China and overseas, researchers have conducted experiments on a dozen variants, including those found in South Africa and the United Kingdom, Zhang said.

    The experiments have found that the antibodies produced by the two inactivated vaccines have a good neutralizing effect on all the tested strains, he said, adding that such experiments are continuing on strains found in Brazil and Zimbabwe.

    Three inactivated vaccines have won conditional approval for market use in China. Two were developed and manufactured by Sinopharm and the other by Sinovac Biotech.

    Zhang said virus mutations will always occur and cannot be prevented, but small mutations will not alter the effectiveness of vaccines.

    Various COVID-19 variants have been identified since late last year. While no evidence has emerged that they cause more severe illness in the majority of infected people, they were found to be more contagious.

    Gao Qiang, general manager of Sinovac Biotech, told the news conference that the company has started research and development of vaccines against the variants discovered in South Africa and Brazil.

    Based on earlier cross-neutralization research on mutated strains found in 10 countries, its vaccine has proved to be effective, he said.

    The two executives said they have gained rich experience in vaccine research and development and will be able to respond quickly and effectively to mutant strains.

    Separately, China had administered more than 100 million doses of COVID-19 vaccines by Saturday, the National Health Commission said.

    The country will actively and prudently advance the COVID-19 vaccination of people over 60 and those who have chronic disease, based on the effectiveness of its mass vaccination campaign, commission official Wu Liangyou said.

    Beijing and Shanghai have started vaccinating people over 60 who are in good health and those who have chronic disease, Wu said.

    Zhang said China National Biotech Group will start consultations with the National Medical Products Administration on the vaccination of those aged between 3 and 17, and it is expected to start soon.

    The company started early and mid-stage clinical trials of vaccinations for people in that age group in Henan province last year, Zhang said.

    The trials have shown that the vaccine's safety met expectations, and data on its effectiveness has also been obtained, he said.

    Wang Huaqing, chief vaccination planning expert at the Chinese Center for Disease Control and Prevention, said although there is no comprehensive late-stage clinical trial data on vaccination of people under 18, it will be obtained as clinical trials progress.

    China has given consideration to vaccinating people under 18, including newborns, and it will continue to improve its vaccination plan based on the epidemic situation and clinical trial data, he said.

    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
     
    日韩精品无码久久久久久| 影院无码人妻精品一区二区 | 中文字幕人妻在线视频不卡乱码| 免费无码毛片一区二区APP| 免费无码国产在线观国内自拍中文字幕 | 日韩人妻精品无码一区二区三区| 最近2019年中文字幕一页| 无码免费又爽又高潮喷水的视频| 亚洲av无码片在线播放| 久久亚洲中文字幕精品有坂深雪| 国产精品无码一区二区三级| 亚洲中文字幕无码永久在线| 国产日韩精品中文字无码| 日韩专区无码人妻| 蜜桃臀无码内射一区二区三区| 十八禁视频在线观看免费无码无遮挡骂过| 亚洲精品无码久久毛片| 2021无码最新国产在线观看| 亚洲精品无码成人片久久| 精品亚洲AV无码一区二区三区| а中文在线天堂| 亚洲av中文无码乱人伦在线播放 | 免费无码中文字幕A级毛片| 亚洲av永久无码精品网站| 日韩av无码中文字幕| 欧美一级一区二区中文字幕| 中文精品无码中文字幕无码专区| 久久久久久国产精品无码下载| 久热中文字幕无码视频| 午夜福利无码不卡在线观看| 一本色道久久HEZYO无码| 久久久久av无码免费网| 精品亚洲AV无码一区二区| 在线播放无码后入内射少妇| 曰韩精品无码一区二区三区| 日韩AV无码一区二区三区不卡毛片 | 久久精品亚洲中文字幕无码麻豆| 少妇无码AV无码专区在线观看| 日韩精品无码专区免费播放| 国产亚洲人成无码网在线观看| 东京热加勒比无码少妇|